Our Services
Medical Information
Helpful Resources
Published on: 5/8/2026
Mixing Shilajit with aspirin can amplify their blood-thinning effects, leading to excessive bruising, prolonged bleeding, and unpredictable aspirin levels due to impacts on platelet function and drug metabolism.
There are several factors to consider. See below for full details on interaction mechanisms, who is most at risk, warning signs to watch for, and safe monitoring strategies.
Shilajit is a popular dietary supplement in traditional medicine, prized for its energy-boosting and anti-inflammatory properties. Aspirin, on the other hand, is a well-known over-the-counter pain reliever and blood thinner. While both can offer health benefits on their own, combining Shilajit and aspirin—or any supplement with blood-thinning effects—can raise safety concerns. Below, we break down what you need to know about Shilajit and blood thinner interactions, based on credible medical research.
Additive Anticoagulant Effect
Impact on Platelet Function
Altered Drug Metabolism
Be alert for warning signs—early recognition can prevent serious complications:
Consult Your Doctor Before Combining
Start Low, Go Slow
Regular Monitoring
Consider Alternative Supplements
Maintain a Balanced Diet
If you experience any of the following, seek urgent medical attention:
If you're unsure about your symptoms or need guidance before deciding to visit the emergency room, try using a Medically approved LLM Symptom Checker Chat Bot to help evaluate whether you need immediate care or can schedule an appointment with your doctor.
This information is intended to help you understand potential interactions between Shilajit and blood thinners like aspirin. It does not replace personalized medical advice. If you're considering combining these substances—or if you experience any concerning symptoms—please speak to a doctor right away, especially if your condition could be life threatening.
(References)
* Sharma PK, Sharma A, Agarwal S. Evaluation of antiplatelet activity of Shilajit in vitro and in vivo. Indian J Pharmacol. 2011 Oct;43(5):548-52. doi: 10.4103/0253-7613.84964. PMID: 21966030.
* Michos KA, Tzioumis E, Tzioumala M, Spandonidis A, Papakonstantinou C, Skrapari I, Tzioumala S, Kountouris A. Antiplatelet therapy: a concise review of aspirin and P2Y12 antagonists. Am J Cardiovasc Drugs. 2015 Apr;15(2):101-14. doi: 10.1007/s40256-015-0112-9. PMID: 25777823.
* Raj VS, Shrivastava S, Singh A, Misra S, Arya A, Saxena S, Singh T, Garg R, Verma SK, Gupta PK. Shilajit: A review of recent research on its therapeutic potential and safety. J Ethnopharmacol. 2021 Oct 28;279:114382. doi: 10.1016/j.jep.2021.114382. PMID: 34186214.
* Mousa MM, El-Dahiyat FM. Potential interactions of herbal medicines with drugs commonly used in cardiovascular disease. Curr Vasc Pharmacol. 2013 May;11(3):288-301. doi: 10.2174/1570161111311030006. PMID: 23692023.
* Agarwal DM, Gupta PK, Singh A, Misra S, Saxena S, Singh T, Garg R, Verma SK, Shrivastava S. Shilajit: A natural multimineral for human health. J Ethnopharmacol. 2023 Jun 12;309:116345. doi: 10.1016/j.jep.2023.116345. PMID: 36980309.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.